Relief Therapeutics Holding SA (ETR:RLF) | WebDisclosure

Basculer en Français

10964	Companies
240038	Keywords
168782	Articles
129139	Press releases

Headlines Articles Press releases Relief Therapeutics Holding SA

Home
Companies
Relief Therapeutics Holding SA

PRESS RELEASE

published on 03/03/2026 at 07:00, 6 months 8 days ago

MindMaze Therapeutics Provides Corporate Update and Publishes March 2026 Investor Presentation
MindMaze Therapeutics provides corporate update and publishes March 2026 investor presentation, focusing on expansion in the US and Europe, organizational restructuring, and governance changes

Expansion Investor Presentation Corporate Update Neurological Diseases MindMaze Therapeutics
BRIEF

published on 12/23/2025 at 07:05, 8 months 19 days ago

MindMaze Therapeutics: Advancing Global Reimbursement Strategies

Healthcare Innovation MindMaze Therapeutics Digital Neurorehabilitation Reimbursement Strategy AI-powered Therapies
BRIEF

published on 12/23/2025 at 07:05, 8 months 19 days ago

MindMaze Therapeutics : Faire progresser les stratégies de remboursement mondiales

Thérapies Basées Sur L'IA Innovation Dans Le Secteur De La Santé MindMaze Thérapeutique Neuroréadaptation Numérique Stratégie De Remboursement
PRESS RELEASE

published on 12/23/2025 at 07:00, 8 months 19 days ago

MindMaze Therapeutics: Consolidating a Global Approach to Reimbursement for Next-Generation Therapeutics
MindMaze Therapeutics Holding SA outlines a global reimbursement strategy for next-generation neurotherapeutics, focusing on scalability and sustainable growth across major healthcare systems

Healthcare Systems MindMaze Therapeutics Global Reimbursement Strategy Neurotherapeutics Reimbursement Durability
BRIEF

published on 12/15/2025 at 07:05, 8 months 27 days ago

Relief Therapeutics and NeuroX Finalize Merger to Form MindMaze Therapeutics

SIX Swiss Exchange Business Merger Neurological Diseases MindMaze Therapeutics Digital Treatments
BRIEF

published on 12/15/2025 at 07:05, 8 months 27 days ago

Relief Therapeutics et NeuroX finalisent leur fusion pour former MindMaze Therapeutics

SIX Swiss Exchange Fusion D'entreprises Maladies Neurologiques Traitements Numériques MindMaze Thérapeutique
PRESS RELEASE

published on 12/15/2025 at 07:00, 8 months 27 days ago

Relief Therapeutics and NeuroX Complete Business Combination and Form MindMaze Therapeutics
Relief Therapeutics and NeuroX complete business combination forming MindMaze Therapeutics. Newly integrated entity aims to redefine neurological care with digital treatments and AI-powered solutions

Business Combination Relief Therapeutics NeuroX MindMaze Therapeutics Neurological Care
BRIEF

published on 11/25/2025 at 07:05, 9 months 16 days ago

Relief Therapeutics and NeuroX Present Financial Outlook for Merger

EBITDA Margin Financial Outlook Relief Therapeutics NeuroX Merger Digital Neurotherapeutics
BRIEF

published on 11/25/2025 at 07:05, 9 months 16 days ago

Relief Therapeutics et NeuroX présentent leurs perspectives financières en vue de leur fusion

Marge D'EBITDA Perspectives Financières Thérapeutiques De Soulagement Fusion NeuroX Neurothérapie Numérique
PRESS RELEASE

published on 11/25/2025 at 07:00, 9 months 16 days ago

Relief Therapeutics and NeuroX Unveil Joint Presentation and Financial Outlook Ahead of Anticipated Business Combination
Relief Therapeutics and NeuroX reveal joint presentation and financial outlook in anticipation of business combination. Financial guidance includes revenue projections and EBITDA margin targets

Business Combination Financial Outlook Relief Therapeutics Press Conference NeuroX

Accesswire

Published on 09/11/2026 at 04:00, 9 hours 1 minute ago

Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 14 hours 36 minutes ago

Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 17:46, 19 hours 15 minutes ago

Groete Access Road Nears Completion
Published on 09/10/2026 at 15:20, 21 hours 41 minutes ago

MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 22 hours 1 minute ago

All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)

View all ACCESSWIRE

EQS Group

Published on 09/11/2026 at 11:45, 1 hour 15 minutes ago

Halfords Group PLC: Result of AGM
Published on 09/11/2026 at 11:43, 1 hour 17 minutes ago

Skyborn reaches Financial Close on the Gennaker offshore wind farm project
Published on 09/11/2026 at 11:35, 1 hour 25 minutes ago

EQS-Adhoc: Correction of a release from 10/09/2026, 19:35 CET/CEST - United Internet AG: Group subsidiaries 1&1 AG and IONOS Group SE launch transformation programs
Published on 09/11/2026 at 11:30, 1 hour 31 minutes ago

Galimedix Therapeutics to present functional feasibility data from Phase 2 eDREAM study in geographic atrophy at 26th EURETINA Congress
Published on 09/11/2026 at 10:15, 2 hours 45 minutes ago

TCMA Receives Two National Awards, Highlighting Thailand’s Cement Industry Progress Towards Net Zero 2050

Les Echos

Published on 09/11/2026 at 07:00, 6 hours 1 minute ago

Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 6 hours 1 minute ago

Transparency notification by Baltisse Group
Published on 09/11/2026 at 07:00, 6 hours 1 minute ago

BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 6 hours 1 minute ago

BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 17 hours 31 minutes ago

Availability of the 2026 Interim Financial Report

View all LES ECHOS COMFI WIRE